现代医药卫生
現代醫藥衛生
현대의약위생
MODERN MEDICINE HEALTH
2014年
11期
1629-1630,1632
,共3页
肝炎,丙型%肝炎病毒属%抗原,病毒%肝炎抗体%酶联免疫吸附测定
肝炎,丙型%肝炎病毒屬%抗原,病毒%肝炎抗體%酶聯免疫吸附測定
간염,병형%간염병독속%항원,병독%간염항체%매련면역흡부측정
Hepatitis C%Hepacivirus%Antigens,viral%Hepatitis antibodies%Enzyme-linked immunosorbent assay
目的:探讨丙型肝炎病毒核心抗原(HCV-cAg)检测在丙型肝炎(丙肝)感染窗口期和免疫异常患者中的临床价值。方法2011年6月至2014年1月分别对丙肝病毒抗体(HCV-Ab)阳性标本153份(Ⅰ组),HCV-Ab阴性血液透析患者、吸毒患者和救助站“三无(无身份证、无工作、无住处)”人员的标本195份(Ⅱ组),HCV-Ab阴性的肿瘤科患者标本207份(Ⅲ组)和HCV-Ab阴性的健康对照标本71份(Ⅳ组),采用酶联免疫吸附试验法检测HCV-cAg;对HCV-cAg检测结果阳性标本进一步检测HCV RNA,对HCV-cAg和HCV-Ab均阳性的吸光度值(S/CO)结果进行比较分析。结果在Ⅰ、Ⅱ、Ⅲ、Ⅳ组中HCV-cAg的阳性率分别为29.4%(45/153)、5.6%(11/195)、3.4%(7/207)、1.4%(1/71);HCV-cAg 与HCV RNA的符合率达95.3%;随着HCV-cAg水平的下降,HCV-Ab水平呈上升趋势。结论 HCV-cAg检测与HCV RNA符合率高,能防止窗口期和免疫异常丙肝患者的漏诊;HCV-cAg与HCV-Ab互为补充关系,二者联合检测能提高丙肝检出率。
目的:探討丙型肝炎病毒覈心抗原(HCV-cAg)檢測在丙型肝炎(丙肝)感染窗口期和免疫異常患者中的臨床價值。方法2011年6月至2014年1月分彆對丙肝病毒抗體(HCV-Ab)暘性標本153份(Ⅰ組),HCV-Ab陰性血液透析患者、吸毒患者和救助站“三無(無身份證、無工作、無住處)”人員的標本195份(Ⅱ組),HCV-Ab陰性的腫瘤科患者標本207份(Ⅲ組)和HCV-Ab陰性的健康對照標本71份(Ⅳ組),採用酶聯免疫吸附試驗法檢測HCV-cAg;對HCV-cAg檢測結果暘性標本進一步檢測HCV RNA,對HCV-cAg和HCV-Ab均暘性的吸光度值(S/CO)結果進行比較分析。結果在Ⅰ、Ⅱ、Ⅲ、Ⅳ組中HCV-cAg的暘性率分彆為29.4%(45/153)、5.6%(11/195)、3.4%(7/207)、1.4%(1/71);HCV-cAg 與HCV RNA的符閤率達95.3%;隨著HCV-cAg水平的下降,HCV-Ab水平呈上升趨勢。結論 HCV-cAg檢測與HCV RNA符閤率高,能防止窗口期和免疫異常丙肝患者的漏診;HCV-cAg與HCV-Ab互為補充關繫,二者聯閤檢測能提高丙肝檢齣率。
목적:탐토병형간염병독핵심항원(HCV-cAg)검측재병형간염(병간)감염창구기화면역이상환자중적림상개치。방법2011년6월지2014년1월분별대병간병독항체(HCV-Ab)양성표본153빈(Ⅰ조),HCV-Ab음성혈액투석환자、흡독환자화구조참“삼무(무신빈증、무공작、무주처)”인원적표본195빈(Ⅱ조),HCV-Ab음성적종류과환자표본207빈(Ⅲ조)화HCV-Ab음성적건강대조표본71빈(Ⅳ조),채용매련면역흡부시험법검측HCV-cAg;대HCV-cAg검측결과양성표본진일보검측HCV RNA,대HCV-cAg화HCV-Ab균양성적흡광도치(S/CO)결과진행비교분석。결과재Ⅰ、Ⅱ、Ⅲ、Ⅳ조중HCV-cAg적양성솔분별위29.4%(45/153)、5.6%(11/195)、3.4%(7/207)、1.4%(1/71);HCV-cAg 여HCV RNA적부합솔체95.3%;수착HCV-cAg수평적하강,HCV-Ab수평정상승추세。결론 HCV-cAg검측여HCV RNA부합솔고,능방지창구기화면역이상병간환자적루진;HCV-cAg여HCV-Ab호위보충관계,이자연합검측능제고병간검출솔。
Objective To investigate the clinical value of the hepatitis C virus core antigen (HCV-cAg) in window period and immune abnormalities of the patients with hepatitis C. Methods A total of 153 positive specimens of antibody to hepatitis C virus(HCV-Ab) (groupⅠ),195 specimens of“three non-personnel”(no ID,no job,no home) in salvation,drug users and hemodial-ysis patients with negative HCV-Ab(groupⅡ),207 specimens with negative HCV-Ab in Oncology Department(groupⅢ) and 71 specimens of healthy control with negative HCV-Ab(groupⅣ) were adopted from June 2011 to January 2014 by enzyme linked immunosorbent assay to detect the HCV-cAg. The HCV RNA in specimens with positive HCV-cAg were further detected,and the absorbance values(S/CO) of the specimen of positive HCV-cAg and HCV-Ab were compared and analyzed. Results The posi-tive rates of HCV-cAg in groupⅠ,Ⅱ,ⅢandⅣwere 29.4%(45/153),5.6%(11/195),3.4%(7/207) and 1.4%(1/71) respec-tively. The coincidence rate of HCV-cAg and HCV RNA reached to 95.3%. With the decline of HCV-cAg level,the level of HCV-Ab reflected upward trend. Conclusion The coincidence rate between HCV-cAg and HCV-RNA is high,HCV-cAg detection can prevent missed diagnosis in the window period and immune abnormalities of HCV patients. HCV-cAg and HCV-Ab show com-plementary relationship,the combined detection can greatly improve the detection rate of hepatitis C.